Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

A Second Target for the Peptoid Tat/Transactivation Response Element Inhibitor CGP64222: Inhibition of Human Immunodeficiency Virus Replication by Blocking CXC-Chemokine Receptor 4-Mediated Virus Entry

Dirk Daelemans, Dominique Schols, Myriam Witvrouw, Christophe Pannecouque, Sigrid Hatse, Sonia van Dooren, François Hamy, Thomas Klimkait, Erik de Clercq and Anne-Mieke VanDamme
Molecular Pharmacology January 2000, 57 (1) 116-124;
Dirk Daelemans
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dominique Schols
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Myriam Witvrouw
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Christophe Pannecouque
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sigrid Hatse
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sonia van Dooren
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
François Hamy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Thomas Klimkait
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erik de Clercq
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Anne-Mieke VanDamme
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 57 no. 1 116-124
PubMed 
10617686

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received April 27, 1999
  • Accepted August 20, 1999
  • Published online January 1, 2000.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Dirk Daelemans1,
  2. Dominique Schols1,
  3. Myriam Witvrouw1,
  4. Christophe Pannecouque1,
  5. Sigrid Hatse1,
  6. Sonia van Dooren1,
  7. François Hamy2,
  8. Thomas Klimkait1,2,
  9. Erik de Clercq1 and
  10. Anne-Mieke VanDamme1
  1. 1Rega Institute for Medical Research, Katholieke Universiteit Leuven, Leuven, Belgium (D.D., D.S., M.W., C.P., S.H., S. Van D., E. De C., A.-M.V.); and 2Novartis Pharmaceuticals, Pharma Research, Basel, Switzerland (F.H., T.K.)
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage: December 1999 to April 2021

    AbstractFullPdf
    Dec 1999330
    Jan 2000187347
    Feb 200042817
    Mar 20003126
    Apr 2000087
    May 20001199
    Jun 20005710
    Jul 2000078
    Aug 20000136
    Sep 20002176
    Oct 2000203
    Nov 20002196
    Dec 20001128
    Jan 200151614
    Feb 20017912
    Mar 20010108
    Apr 2001989
    May 2001065
    Jun 20014512
    Jul 2001066
    Aug 2001123
    Sep 200111010
    Oct 2001247
    Nov 2001058
    Dec 20011313
    Jan 20020910
    Feb 2002085
    Mar 200201419
    Apr 20021128
    May 2002042
    Jun 2002186
    Jul 2002285
    Aug 2002158
    Sep 2002140
    Oct 2002023
    Nov 2002066
    Dec 2002588
    Jan 2003132
    Feb 200321111
    Mar 200311511
    Apr 2003045
    May 2003234
    Jun 2003465
    Jul 20039238
    Aug 20037246
    Sep 200312264
    Oct 20038150
    Nov 200316214
    Dec 200310247
    Jan 200413319
    Feb 20048172
    Mar 200413347
    Apr 2004114214
    May 200414177
    Jun 200424353
    Jul 200418219
    Aug 200413172
    Sep 2004162213
    Oct 200416338
    Nov 200410283
    Dec 200413205
    Jan 200514184
    Feb 20059189
    Mar 20059255
    Apr 200562316
    May 20059345
    Jun 20057168
    Jul 2005102214
    Aug 20057163
    Sep 2005283
    Oct 20059134
    Nov 20059179
    Dec 200552010
    Jan 20066209
    Feb 20068256
    Mar 20063223
    Apr 20064123
    May 2006382
    Jun 20064135
    Jul 20065103
    Aug 20067146
    Sep 20065104
    Oct 200671114
    Nov 20061157
    Dec 2006786
    Jan 200791113
    Feb 20073126
    Mar 2007493
    Apr 20077237
    May 20075158
    Jun 20074114
    Jul 20071195
    Aug 20074146
    Sep 20074125
    Oct 20075133
    Nov 20074135
    Dec 20074157
    Jan 20088116
    Feb 20081267
    Mar 20084165
    Apr 20082295
    May 2008736
    Jun 20085164
    Jul 200817137
    Aug 200824257
    Sep 200829135
    Oct 200821124
    Nov 2008788
    Dec 2008360
    Jan 2009573
    Feb 200971810
    Mar 200920203
    Apr 20095135
    May 200911101
    Jun 2009683
    Jul 20091394
    Aug 2009553
    Sep 20091869
    Oct 20092320
    Nov 20091675
    Dec 2009836
    Jan 20107105
    Feb 2010448
    Mar 2010894
    Apr 201021305
    May 2010571
    Jun 20102115
    Jul 2010563
    Aug 20105163
    Sep 2010852
    Oct 2010643
    Nov 201012125
    Dec 201010143
    Jan 201119135
    Feb 20116142
    Mar 20116185
    Apr 2011985
    May 20116144
    Jun 201112179
    Jul 2011692
    Aug 20117102
    Sep 201112186
    Oct 20111162
    Nov 20118154
    Dec 2011896
    Jan 201210114
    Feb 20129712
    Mar 201210125
    Apr 20125830
    May 201212511
    Jun 2012669
    Jul 2012785
    Aug 2012161511
    Sep 201212711
    Oct 201291216
    Nov 20121167
    Dec 2012141415
    Jan 2013533710
    Feb 201323188
    Mar 2013984
    Apr 201321136
    May 201312811
    Jun 20133712
    Jul 2013238
    Aug 2013264
    Sep 2013525
    Oct 2013154
    Nov 2013582
    Dec 2013482
    Jan 2014723
    Feb 2014466
    Mar 2014398
    Apr 2014874
    May 20149613
    Jun 20141057
    Jul 2014423
    Aug 2014435
    Sep 2014120
    Oct 20141554
    Nov 20141261
    Dec 2014713
    Jan 2015731
    Feb 2015350
    Mar 2015581
    Apr 2015763
    May 2015762
    Jun 2015692
    Jul 201512147
    Aug 20158115
    Sep 20151362
    Oct 2015031
    Nov 2015633
    Dec 2015771
    Jan 2016256
    Feb 20161026
    Mar 20161577
    Apr 2016220
    May 20168115
    Jun 20162563
    Jul 20161274
    Aug 20161141
    Sep 2016744
    Oct 2016533
    Nov 20160102
    Dec 201601510
    Jan 2017282
    Feb 2017151
    Mar 20171115
    Apr 2017044
    May 20172133
    Jun 2017082
    Jul 2017083
    Aug 2017151
    Sep 20171154
    Oct 20171551
    Nov 20171110
    Dec 20170203
    Jan 2018091
    Feb 2018541
    Mar 20182112
    Apr 20180144
    May 2018043
    Jun 20182111
    Jul 20182103
    Aug 2018132
    Sep 2018031
    Oct 2018061
    Nov 2018055
    Dec 2018922
    Jan 2019200
    Feb 2019611
    Mar 20191800
    Apr 2019300
    May 2019300
    Jun 2019402
    Jul 2019922
    Aug 20191010
    Sep 2019802
    Oct 20191200
    Nov 2019902
    Dec 20192212
    Jan 2020311
    Feb 20201010
    Mar 2020422
    Apr 2020200
    May 2020220
    Jun 2020200
    Jul 2020200
    Aug 2020110
    Sep 2020210
    Oct 2020100
    Nov 2020610
    Dec 2020711
    Jan 2021451
    Feb 2021951
    Mar 2021732
    Apr 2021610

    PreviousNext
    Back to top

    In this issue

    Molecular Pharmacology: 57 (1)
    Molecular Pharmacology
    Vol. 57, Issue 1
    1 Jan 2000
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Molecular Pharmacology article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    A Second Target for the Peptoid Tat/Transactivation Response Element Inhibitor CGP64222: Inhibition of Human Immunodeficiency Virus Replication by Blocking CXC-Chemokine Receptor 4-Mediated Virus Entry
    (Your Name) has forwarded a page to you from Molecular Pharmacology
    (Your Name) thought you would be interested in this article in Molecular Pharmacology.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    A Second Target for the Peptoid Tat/Transactivation Response Element Inhibitor CGP64222: Inhibition of Human Immunodeficiency Virus Replication by Blocking CXC-Chemokine Receptor 4-Mediated Virus Entry

    Dirk Daelemans, Dominique Schols, Myriam Witvrouw, Christophe Pannecouque, Sigrid Hatse, Sonia van Dooren, François Hamy, Thomas Klimkait, Erik de Clercq and Anne-Mieke VanDamme
    Molecular Pharmacology January 1, 2000, 57 (1) 116-124;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Share
    Research ArticleArticle

    A Second Target for the Peptoid Tat/Transactivation Response Element Inhibitor CGP64222: Inhibition of Human Immunodeficiency Virus Replication by Blocking CXC-Chemokine Receptor 4-Mediated Virus Entry

    Dirk Daelemans, Dominique Schols, Myriam Witvrouw, Christophe Pannecouque, Sigrid Hatse, Sonia van Dooren, François Hamy, Thomas Klimkait, Erik de Clercq and Anne-Mieke VanDamme
    Molecular Pharmacology January 1, 2000, 57 (1) 116-124;
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Allosteric Modulation of NMDA Receptor Conductance
    • 6-Methylflavone Blocks Bitterness of Tenofovir
    • Positive Allosteric Modulation of the mGlu5 Receptor
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About Molecular Pharmacology
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0111 (Online)

    Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics